These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2562645)

  • 21. The enhancement of host defenses against infection--search for the Holy Grail?
    Polk HC
    Surgery; 1986 Jan; 99(1):1-6. PubMed ID: 3941994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of immune responses by muroctasin.
    Akasaki M
    Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muramyl peptide enhancement of slow-wave sleep.
    Krueger JM
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):105-10. PubMed ID: 3713370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
    Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
    Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of interleukin 1 by synthetic and naturally occurring muramyl peptides.
    Dinarello CA; Krueger JM
    Fed Proc; 1986 Oct; 45(11):2545-8. PubMed ID: 3489643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide.
    Bahr GM
    J Antimicrob Chemother; 2003 Jan; 51(1):5-8. PubMed ID: 12493780
    [No Abstract]   [Full Text] [Related]  

  • 27. Specific binding sites for muramyl peptides on murine macrophages.
    Silverman DH; Krueger JM; Karnovsky ML
    J Immunol; 1986 Mar; 136(6):2195-201. PubMed ID: 3950411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope specific immunity elicited by totally synthetic monovalent or polyvalent vaccines.
    Chedid L; Audibert F; Jolivet M; Carelli C; Uzan M; Gras-Masse H; Tarter A
    Ann Sclavo Collana Monogr; 1984; 1(2):77-85. PubMed ID: 6400358
    [No Abstract]   [Full Text] [Related]  

  • 29. Muramyl peptides in mammalian tissues and their effects at the cellular level.
    Karnovsky ML
    Fed Proc; 1986 Oct; 45(11):2556-60. PubMed ID: 3758374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential adjuvants for synthetic vaccines. I. Modulators of macrophage activation.
    Solange A
    Chem Phys Lipids; 1995 Jan; 75(1):51-8. PubMed ID: 7697782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental and clinical studies on the effects of synthetic muramyldipeptide derivatives on viral and opportunistic infections.
    Yamamura Y; Ishihara C; Hamada N; Yamamoto K; Azuma I
    Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):11-4. PubMed ID: 3010013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use].
    Castrillón LE
    Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614
    [No Abstract]   [Full Text] [Related]  

  • 34. [Natural immunostimulants].
    Nikitin AV; Navashin SM
    Antibiotiki; 1983 Sep; 28(9):702-16. PubMed ID: 6357066
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of novel derivatives of muramyl dipeptide on the immune system].
    Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa
    Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of muramyl peptides in viral vaccines].
    Krivorutchenko IuL
    Vopr Virusol; 1999; 44(1):4-8. PubMed ID: 10190232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of human endothelial cells by synthetic muramyl peptides: production of colony-stimulating activity (CSA).
    Galelli A; Dosne AM; Morin A; Dubor F; Chedid L
    Exp Hematol; 1985 Dec; 13(11):1157-63. PubMed ID: 3877645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep factors: do muramyl peptides activate serotonin binding sites?
    Root-Bernstein RS; Westall FC
    Lancet; 1983 Mar; 1(8325):653. PubMed ID: 6131333
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inhibition of IgE antibody formation by tubercle bacilli and muramyl peptide].
    Kishimoto T
    Kekkaku; 1980 Oct; 55(10):467-70. PubMed ID: 6785511
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunomodulatory properties of new conjugates of muramyl dipeptide and nor-muramyl dipeptide with retro-tuftsin (Arg-Pro-Lys-Thr-OMe).
    Wardowska A; Dzierzbicka K; Trzonkowski P; Myśliwski A
    Int Immunopharmacol; 2006 Oct; 6(10):1560-8. PubMed ID: 16919828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.